Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant
Vasomotor symptoms (VMS) have a major impact on quality-of-life in women with hormone receptor–positive breast cancer receiving adjuvant endocrine therapy. As menopause hormone therapy is contraindicated in this setting, effective non-hormonal treatment options are urgently needed. We performed a fo...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2026-08-01
|
| Serie: | Breast |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S0960977626001220 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|